Home   |   Email   |  Imprint      

Clinical Need Standard of Care Clinical Data The Diramo system The Glycostat system

Company Team



Blood glucose control systems for intensive care

Flowsion A/S is developing Diramo and Glycostat.
Diramo is an intravenous sensor specifically for tight glycemic control (TGC) in the critical care market. The Diramo system is intended to continuously measure, record and track the blood glucose level (BGL) in critically ill patients (i.e., those patients under intensive-care treatment within an ICU) and to provide appropriate alarms in case of hypo- and hyperglycemic readings by the device.

The Glycostat system is intended to keep the blood Glucose level within set limits using closed loop control.

Flowsion A/S 2013. All rights reserved. CAUTION - Investigational device